Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Overview Structured Data Issues Contributors Activity

emergencetx.com

Is a

Company

Organization

Company attributes

Industry

Biotechnology

Manufacturing

Pharmaceutical industry

Location

B2X

CEO

Number of Employees (Ranges)

1 – 10

Email Address

info@emergencetx.com0

Full Address

Schifferstrasse 210 47059 Duisburg Germany0

17 Boulevard Augustin Cieussa 13007 Marseille France0

Investors

Gruenderfonds Ruhr

Hadean Ventures

Founded Date

January 1, 2019

Total Funding Amount (USD)

191,300,000

Latest Funding Round Date

December 13, 2021

CFO

Latest Funding Type

Country

Headquarters

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

92,300,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Emergence Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API